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Vasohibin is thought to be an important negative feedback regulator of angiogenesis that is selec-
tively induced in endothelial cells by VEGF. Here, we assessed the role of vasohibin on HIF-1a expres-
sion under oxidative stress induced by hydrogen peroxide (H2O2) in HUVEC. VEGF induced
signiﬁcant cell growth that was associated with an increase in vasohibin expression. Following
H2O2-pretreatment, VEGF further increased cell growth but this was contrastingly associated with
a decrease in vasohibin expression when compared with VEGF alone. Interestingly, vasohibin inhib-
ited cell proliferation through degradation of HIF-1a expression during H2O2-pretreatment. Further-
more, vasohibin elevated the expression of prolyl hydroxylase (PHD). These results suggest that
vasohibin plays crucial roles as a negative feedback regulator of angiogenesis through HIF-1a deg-
radation via PHD.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Vasohibinwas identiﬁed in the humanbrain [1] and is thought to
be the ﬁrst negative feedback regulator of angiogenesis. It is selec-
tively induced in endothelial cells by proangiogenic stimulatory
growth factors such as vascular endothelial growth factor (VEGF)
[2,3]. The expression of vasohibin is evident in various pathological
conditions including cancers [4,5], atherosclerosis [6] and diabetic
retinopathy [7]. Recent reports indicate that Vasohibin is expressed
not only in endothelial cells but also in other cell types including
haematopoietic cells [8]. Vasohibin has no inﬂuence on in vitro pro-
liferation of tumor cells but does result in a signiﬁcant reduction in
largevessels andvascular area in vasohibin-overexpressingmelano-
mas [3,9]. On the other hand, overexpression of vasohibin induces
apoptosis in proliferating human ﬁbroblasts, but does not affectchemical Societies. Published by E
hypoxia-inducible factor-1a;
D, prolyl hydroxylase; ROS,
al growth factor; VHL, von
iochemistry, Faculty of Phar-
nakuma, Jonan-ku, Fukuoka
.keratinocyte cell growth [10]. Therefore, vasohibin could serve as a
potential anti-tumor drug by manipulating tumor angiogenesis.
The hypoxia-inducible factor (HIF) transcription factor family
form a/b heterodimeric DNA binding complexes and direct an
extensive transcriptional response involving the induction of genes
relevant to tumor progression, such as VEGF that promotes angio-
genesis, glucose/energy metabolism, cellular growth, and apopto-
sis [11,12]. The HIF-a subunit interacts with von Hippel–Lindau
(VHL) protein and is degraded by ubiquitin-mediated proteolysis
via prolyl hydroxylase (PHD) in the presence of oxygen [13]. Regu-
lation by oxygen is mediated by the a subunits (HIF-1a, HIF-2a,
and HIF-3a), and recently it has been shown that control by oxygen
involves novel signaling pathways mediated by enzymatic hydrox-
ylation of speciﬁc amino acid residues in these proteins [14]. HIF-
1a protein is ubiquitously expressed, whereas its homologs HIF-2a
and HIF-3a have more restricted expression patterns [15]. Under
lower oxygen tension, hydroxylation is inhibited because of sub-
strate (O2) deprivation, and HIF-1a accumulates, dimerizes with
HIF-1b, and mediates profound changes in hypoxia-inducible gene
expression [16]. Hypoxia-induced oxidative stress is caused by an
overgeneration of reactive oxygen species (ROS), which may be in-
volved in the increase of HIF-1a mRNA [17,18].
Thus, HIF-1a is a key regulator of responses to oxidative stress,
but the relationship between vasohibin and HIF-1a underlsevier B.V. All rights reserved.
Fig. 1. Effect of VEGF and H2O2 on HUVEC proliferation. HUVECs were pretreated
with or without H2O2 (20 nM) for 24 h prior to treatment with VEGF (0–4 nM).
Viability of the cultured cells was measured by WST-8 assay. Cells cultured in the
absence of VEGF and H2O2 were assigned a relative viability of 100%. Data are
means ± S.E. from six independent experiments. ⁄P < 0.01 vs. 0 nM (VEGF).
#P < 0.005 vs. None (H2O2).
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this study, we set out to assess the role of vasohibin on HIF-1a
expression under oxidative stress induced by hydrogen peroxide
(H2O2) in human umbilical vein endothelial cells (HUVECs). We
demonstrate that H2O2-pretreatment followed by VEGF stimula-
tion increased cell growth which was associated with a decrease
in vasohibin expression as compared with VEGF alone. The degra-
dation of vasohibin protein and mRNA induced by H2O2 was dose-
dependent. We found that vasohibin inhibited cell proliferation
through the degradation of HIF-1a expression under H2O2-pre-
treatment, especially in the nucleus. We also show that vasohibin
elevated PHD, which regulates prolyl hydroxylation of HIF leading
to ubiquitin-mediated proteasomal degradation and VHL recogni-
tion [19–21].
2. Materials and methods
2.1. Cell culture
Cryo-preserved HUVECs and EGM-2 culture medium were pur-
chased from Sanko Junyaku (Tokyo, Japan). EGM-2 is composed of
modiﬁed MCDB 131 medium and supplements that contain FBS,
VEGF, epidermal growth factor, basic ﬁbroblast growth factor,
insulin-like growth factor, heparin, ascorbic acid, hydrocortisone,
amphotericin B and gentamicin. HUVECs were grown in EGM-2
at 37 C in a humidiﬁed 5% CO2 atmosphere. All experiments were
performed with HUVECs at passages 3–5 [22–24].
2.2. Reagents
The following reagentswereobtained commercially: fetal bovine
serum (FBS) and Dulbecco’smodiﬁed Eagle’smedium (DMEM) from
Invitrogen (Carlsbad, CA); recombinant humanVEGF from R&D Sys-
tem (La Jolla, CA); humanvasohibinpeptide (PHRRNSRSERRPSGDKK
TS) from BONAC (Kurume, Japan).
We used primary antibodies against vasohibin, HIF-1a, b-actin
from Santa Cruz Biotechnology (Santa Cruz, CA), PHD-1, PHD-2
and PHD-3 from BETHYL Laboratories, Inc. (Montgomery, TX).
Horseradish peroxidase-conjugated secondary antibodies were
purchased from Vector Laboratories (Burlingame, CA).
2.3. Protein extraction and western blot analysis
Whole-cell extracts were lysed in RIPA Lysis Buffer (Santa Cruz
Biotechnology). Cytoplasmic and nuclear extracts were obtained
using NE-PER Nuclear and Cytoplasmic Extraction Reagents accord-
ing to the manufacturer’s protocols (Pierce Biotechnology, Rock-
ford, IL). Whole-cell, cytoplasmic, and nuclear extracts were used
immediately or stored at 80 C before separation by SDS–PAGE,
electroblotting onto Immobilon-P membranes (Millipore, Billerica,
MA), and analysis for immunoreactivity with the appropriate pri-
mary and secondary antibodies, as indicated in the ﬁgures. Reaction
products were visualized using Chemi-Lumi One L (Nacalai Tesque,
Kyoto, Japan) according to the manufacturer’s protocols.
2.4. Cell viability assay
The effects of sirtinol on cell viability were examined using the
cell proliferation reagent, water-soluble tetrazolium (WST)-8
(Wako Chemicals, Osaka, Japan). Brieﬂy, aliquots of 5  103 cells/
ml were incubated in 96-well plates. After cultivation, 10 lM
WST-8 was added for the last 2 h of incubation and absorbance
at 450 nm (A450) was measured using an automated microplate
reader. Measurement of mitochondrial dehydrogenase cleavage
of WST-8 to formazan dye provides an indication of the level of cell
viability.2.5. Reverse transcription PCR
Total RNA was extracted from PBMCs and cell lines using Trizol
(Invitrogen) according to the manufacturer’s protocols. First-strand
cDNAwas synthesized in a 25 ll reaction volume using SuperScript
One-Step (Invitrogen). Subsequently, cDNA for vasohibin and GAP-
DH was ampliﬁed. The oligonucleotide primers used were as
follows: vasohibin, sense 50-ATACCGAGTGTGCCTACGTT-30 and
antisense 50-CAATCTTGAGCCGCATGTCG-30; GAPDH, sense 50-ACCA
CAGTCCATGCCATCAC-30 and antisense 50-TCCACCACCCTGTTGCTG-
TA-30. The ampliﬁcation programs were as follows: vasohibin,
denaturation at 94 C for 1 min, annealing at 50 C for 1 min, and
extension at 72 C for 2 min, 33 cycles; GAPDH, denaturation at
94 C for 1 min, annealing at 58 C for 1 min, and extension at
72 C for 1 min, 22 cycles. The PCR products were separated on 2%
agarose gels and visualized by ethidium bromide staining. The gel
was photographed with Polaroid-type ﬁlm after staining with ethi-
dium bromide, and the intensity of ethidium bromide ﬂuorescence
in each band was assessed using NIH Image software [25,26].
2.6. Statistical analysis
All values are expressed as the mean ± S.E., and the signiﬁcance
levels between groups were assessed by Student’s t-test. In all
tests, P < 0.05 was considered statistically signiﬁcant.
3. Results and discussion
3.1. H2O2 increased proliferation via suppression of vasohibin
expression in HUVECs
We ﬁrst assessed the proliferation of HUVECs in the presence of
VEGF or H2O2 (Fig. 1). VEGF increased cell proliferation, peaking at
0.5 nM, while pretreatment with H2O2 (20 nM) for 24 h further en-
hanced the VEGF-increased proliferation in HUVECs. ROS act as sig-
naling molecules in many aspects of growth factor-mediated
physiological responses [27]. ROS derived from NAD(P)H oxidase
are critically important for VEGF signaling in vitro and angiogenesis
in vivo [28], and recent reports suggest that ROS play an important
role in angiogenesis [29]. These results suggest that there is a neg-
ative feedback control system in VEGF-induced cell proliferation
and that system may be abrogated following H2O2-pretreatment.
Next, we evaluated the expression of vasohibin, a protein postu-
lated to be an important negative feedback inhibitor of VEGF signal-
ing [2,3], in the presence of VEGF following H2O2 pretreatment
(Fig. 2A). Western blotting showed that VEGF-treatment dose-
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VEGF stimulation following H2O2-pretreatment decreased the
expression of vasohibin compared with VEGF-treatment. The
degradation of vasohibin protein induced by H2O2 was dose-depen-Fig. 2. Effect of VEGF and H2O2 on the expression of vasohibin in HUVECs. HUVECs
were pretreated with or without H2O2 (20 nM) for 24 h prior to treatment with
VEGF (0–2 nM) (A). HUVECs were treated with or without H2O2 (20 nM) and
stimulated with VEGF (0.5 nM) for 24 h (B, C). Protein levels were detected by
western blotting with antibodies directed against the indicated proteins (A, B).
Vasohibin mRNA expression was analyzed by RT-PCR. GAPDH was used as a control
to calculate relative expression levels (C). Cells cultured in the absence of VEGF and
H2O2 were assigned a relative intensity of 1 (A). Cells cultured in the absence of
H2O2 under VEGF (0.5 nM) were assigned a relative intensity of 1 (B, C). Data are
means ± S.E. from four independent experiments. ⁄P < 0.005 vs. 0 nM (VEGF).
#P < 0.005, ##P 6 0.05 vs. None (H2O2).dent (Fig. 2B). In addition, there was a reduction in vasohibinmRNA
expression induced by H2O2 (Fig. 2C). Thus, VEGF induced signiﬁ-
cant cell growth associated with an increase in vasohibin expres-
sion, while H2O2-pretreatment increased cell growth with a
contrasting decrease in vasohibin expression, especially at the level
of protein stability or synthesis. These results suggest that a nega-
tive feedback control system mediated via vasohibin may be mod-
ulated under H2O2-treatment.
The down-regulation of vasohibin protein by H2O2-pretreat-
ment also occurred in the absence of VEGF (Fig. 2A). However,
there was no difference in the proliferation of HUVECs between
groups pre-treated with or without H2O2 (Fig. 1). Thus, the pres-
ence of VEGF may be more important than the degradation of vaso-
hibin in the proliferation of HUVECs.
3.2. Vasohibin suppressed nuclear import of HIF-1a in HUVECs
HIF-1a is a key regulator of responses to oxidative stress
[16,17], but there is currently no description of the relationship be-
tween vasohibin and HIF-1a under oxidative stress. To investigate
the effect of vasohibin on HIF-1a, we ﬁrst examined whether vaso-
hibin affects the viability of HUVECs under oxidative stress. VEGF
increased HUVEC cell proliferation, while vasohibin inhibited
VEGF-induced cell proliferation (Fig. 3A). Vasohibin also inhibited
VEGF-induced cell proliferation under oxidative stress conditions
(Fig. 3B). Thus, 10 nM vasohibin inhibited cell proliferation com-
pared to control levels in the presence or absence of H2O2. Next,
we assessed HIF-1a expression in the presence of vasohibin
(10 nM) under oxidative stress (Fig. 3C). H2O2 treatment enhanced
the expression of HIF-1a in the presence of VEGF. The addition of
VEGF concentrations up to 2 nM did not increase HIF-1a expres-
sion. Interestingly, vasohibin inhibited HIF-1a expression under
oxidative stress conditions.
HIF-1a translocates to the nucleus and peri-nuclear areas fol-
lowing hypoxia [17], and functions to facilitate the adaptation of
cells and tissues to low O2 concentrations [30]. We therefore deter-
mined the localization of HIF-1a in the presence of vasohibin. Wes-
tern blot analysis showed that there was a marked increase of
nuclear HIF-1a protein induced by VEGF. Nuclear HIF-1a protein
levels in the presence of VEGF and vasohibin were decreased, while
those in the cytoplasm were not signiﬁcantly changed (Fig. 4A).
The changes induced by vasohibin were shown to be statistically
signiﬁcant on analysis of the relative intensities (Fig. 4B). These re-
sults suggest that vasohibin suppress the translocation or expres-
sion of HIF-1a and inhibits the proliferation of HUVECs.
3.3. Vasohibin induced PHD expression in HUVECs
It has been demonstrated that the transcription and translation
of HIF-1a are constitutive, and its levels are regulated by the deg-
radation rate [31]. Prolyl hydroxylation of HIF by PHDs leads to
ubiquitin-mediated proteasomal degradation [19–21]. In vitro
and forced expression studies have indicated that each of three clo-
sely related PHDs (1–3) has the potential to hydroxylate HIF-a sub-
units [32]. In this study, vasohibin inhibited HIF-1a expression
following H2O2-pretreatment, especially in the nucleus. We then
assessed the expression of PHD-1, PHD-2 and PHD-3 in HUVECs
after vasohibin exposure following H2O2-pretreatment.Vasohibin
elevated the expression of PHD-1, PHD-2 and PHD-3 in the nucleus
when compared to H2O2-pretreatment alone (Fig. 4C). These
results suggest that the degradation of HIF-1a by vasohibin under
H2O2-pretreatment may be mediated by PHD expression.
Under normal oxygen conditions, HIF-1a, the active subunit of
HIF-1, is hydroxylated on proline residues by speciﬁc HIF prolyl-
hydroxylases, leading to ubiquitination and degradation by the
proteasome [14]. In hypoxia, hydroxylation and ubiquitination
Fig. 3. Effect of vasohibin on the proliferation and the expression of HIF-1a in HUVECs. HUVECs were incubated with vasohibin in the absence (A) or presence (B) of H2O2 for
24 h. Viability of the cultured cells was measured by WST-8 assay. Cells cultured in the absence of VEGF and H2O2 were assigned a relative viability of 100%. HUVECs were
treated with or without VEGF (0–2 nM), H2O2 (20 nM) and vasohibin (10 nM) for 24 h (C). Protein levels were detected by western blotting with antibodies directed against
the indicated protein. Cells cultured in the absence of VEGF, H2O2 and vasohibin were assigned a relative intensity of 1. Data are means ± S.E. from four independent
experiments. #P < 0.01 vs. None. P < 0.005 vs. 20 nM (H2O2).
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treatment elevated HIF-1a expression in HUVECs (Fig. 3C). On the
other hand, H2O2-pretreatment elevated the expression of PHD-1
and PHD-3 in the absence of vasohibin, while PHD-2 expression
was decreased (Fig. 4C), an effect that was also time-dependent
(data not shown). In human cells, PHD-2 is downregulated after
TGF-b1 treatment, allowing the stabilization of HIF-1a [34]. Berra
et al. also reported a dominant effect of PHD-2 suppression in rais-
ing levels of HIF-1 in normoxic cells [35], because in most cells
PHD-2 is by far the most abundant HIF prolyl hydroxylase under
these conditions. These results suggest that PHD-2 is the key en-
zyme responsible for HIF-1a regulation. Importantly, however,
they also demonstrate that both PHD-1 and PHD-3 contribute tothe regulation of the system and that, at least for PHD-3, the
contribution may be as great or greater than that of PHD-2 under
appropriate conditions. Thus, the expression of PHD-1, PHD-2
and PHD-3 may be individually susceptible under oxidative stress.
This study demonstrated that VEGF stimulation of HUVECs fol-
lowing H2O2-pretreatment increased cell growth with an associ-
ated decrease in vasohibin expression when compared with
VEGF-treatment. We also demonstrated that vasohibin inhibited
the HIF-1a expression following H2O2-pretreatment via PHD, espe-
cially in the nucleus. These results suggest that vasohibin plays a
crucial role as a negative feedback regulator of angiogenesis
through the PHD-mediated degradation of HIF-1a. Therefore, vaso-
hibin protein could inhibit the proliferation of endothelial cells by
Fig. 4. Effects of vasohibin on the localization of HIF-1a and the expression of PHD
in HUVECs. HUVECs were treated with or without VEGF (0–2 nM) and vasohibin
(10 nM) following pretreatment with H2O2 (20 nM) for 24 h. Cell extracts from the
cytoplasm and nucleus of treated cells were immunoblotted with speciﬁc antibod-
ies (A). Cells cultured in the absence of VEGF and vasohibin were assigned a relative
intensity of 1 and relative intensities were analyzed (B). HUVECs were treated with
or without H2O2 (20 nM) and vasohibin (10 nM), and stimulated with VEGF
(0.5 nM) for 24 h (C). Protein levels in the nucleus were detected by western
blotting with antibodies directed against the indicated protein. Cells cultured in the
absence of H2O2 and vasohibin were assigned a relative intensity of 1. Data are
means ± S.E. from three independent experiments. P < 0.005 vs. 20 nM (H2O2).
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manipulating tumor angiogenesis.
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